Jared Rice: Anemia of Prematurity is Not Simply an EPO Deficiency
Jared Rice, Nurse Professional Development Specialist at Cleveland Clinic, shared a post on LinkedIn:
“Anemia of prematurity is not EPO deficiency.
It is EPO suppression, and that distinction has direct implications for how you interpret lab values, when you initiate ESA therapy, and why iron is foundational rather than adjunctive.
The HIF-EPO regulatory loop works exactly as designed in the preterm infant
. The problem is that it is running in a postnatal oxygen environment it was never calibrated for, through a producing organ that has not completed its developmental transition, while phlebotomy accelerates the hemoglobin decline faster than the system can compensate.
If you have ever wanted to know what newborns experience anemia and how ESA therapy helps, look at this video.”
Stay updated with Hemostasis Today.
-
Sep 30, 2026, 15:58Bernhard Merget: New Frontiers in Thrombosis and Stroke Research
-
Sep 30, 2026, 15:39Ifeanyichukwu Ifechidere: The Molecular Orchestra of Primary Hemostasis
-
Sep 30, 2026, 15:28Reassessing the Benefit–Risk Balance of Extended Anticoagulation in Cancer Patients – ESC Working Group on Cardiovascular Pharmacotherapy
-
Sep 30, 2026, 15:07Chiranjeev Sharma: Targeting Factor XIa with the Synthetic Inhibitor SB-01
-
Sep 30, 2026, 14:41Bruna Gigante: Balancing Thrombosis and Bleeding in Cardiovascular Care
-
Sep 30, 2026, 14:13Ashok Choudhury: Portal Vein Thrombosis and Outcomes in Cirrhosis
-
Sep 30, 2026, 13:57Leslye Conde Bazán: When Conventional Imaging Is Not Enough – The Role of IVUS
-
Sep 30, 2026, 13:41Huda Salah Eldin: The Challenge of Balancing Antithrombotic Therapy After PCI
-
Sep 30, 2026, 13:29Abdus Salam: What Can CT Venography Reveal About the Veins?